Clarus Group’s CME Group CME Stock Holding History

Clarus Group’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,527	Closed	-$300K	–	115
2024 Q2	$300K	Sell	1,527 -132	-8%	-$27.3K	0.13%	85
2024 Q1	$357K	Buy	1,659 +125	+8%	+$26.3K	0.25%	68
2023 Q4	$323K	Buy	+1,534	New	+$327K	0.24%	76

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Clarus Group's CME Position: Q3 2024 in Review

Clarus Group sold out of CME Group (CME) in Q3 2024, closing a stake of 1,527 shares — an estimated $300K sold.

Clarus Group first reported a position in CME in Q4 2023 and held it in 3 quarters. The position peaked at $357K in Q1 2024. 1,390 funds tracked by Wall St. Rank hold CME as of Q3 2024.

Clarus Group reported no remaining CME Group position as of Q3 2024 after selling out during the quarter.
Clarus Group sold 1,527 CME Group shares in Q3 2024, an estimated $300K.
Clarus Group first reported a position in CME Group in Q4 2023 and held it in 3 quarters.
Clarus Group's CME Group position peaked at $357K in Q1 2024.
1,390 funds tracked by Wall St. Rank held CME Group as of Q3 2024.

Based on Clarus Group's 13F filing for Q3 2024, filed 21 Oct 2024.